Cargando…
PASylated Thymosin α1: A Long-Acting Immunostimulatory Peptide for Applications in Oncology and Virology
Thymosin α1 (Tα1) is an immunostimulatory peptide for the treatment of hepatitis B virus (HBV) and hepatitis C virus (HCV) infections and used as an immune enhancer, which also offers prospects in the context of COVID-19 infections and cancer. Manufacturing of this N-terminally acetylated 28-residue...
Autores principales: | Binder, Uli, Skerra, Arne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7795856/ https://www.ncbi.nlm.nih.gov/pubmed/33374407 http://dx.doi.org/10.3390/ijms22010124 |
Ejemplares similares
-
Direct Affinity Purification of Long‐Acting PASylated Proteins with Therapeutic Potential Using L‐Prolinamide for Mild Elution
por: Schilz, Jonas, et al.
Publicado: (2022) -
PASylation: a biological alternative to PEGylation for extending the
plasma half-life of pharmaceutically active proteins
por: Schlapschy, Martin, et al.
Publicado: (2013) -
High contrast tumor imaging with radio-labeled antibody Fab fragments tailored for optimized pharmacokinetics via PASylation
por: Mendler, Claudia T, et al.
Publicado: (2014) -
Effective rational humanization of a PASylated anti-galectin-3 Fab for the sensitive PET imaging of thyroid cancer in vivo
por: Peplau, Emanuel, et al.
Publicado: (2021) -
Improvement of Certolizumab Fab′ properties by PASylation technology
por: Mazaheri, Somayeh, et al.
Publicado: (2020)